European Journal of Pharmaceutical Sciences 2015-07-30

Design and evaluation of a specific, bi-phase extended release system based on differently coated mini-tablets.

Aleksandar Aleksovski, Matevž Luštrik, Rok Šibanc, Rok Dreu

Index: Eur. J. Pharm. Sci. 75 , 114-22, (2015)

Full Text: HTML

Abstract

Mini-tablets are gaining great attention as systems capable of being formulated into multiple unit systems providing a specific drug release pattern. Within the presented research a combined, multiple-unit system, based on different coated matrix mini-tablets, has been developed in order to achieve 24-h specific sigmoid extended release of the model drug paliperidone. The mini-tablets were based on different amounts of polyvinyl acetate/polyvinyl pyrolidone mixture as the matrix former, providing extended release, and two different types of pH-dependent, acrylic polymer coatings, providing delay in release onset, and thus achieving the required specific sigmoid release pattern imposed by the original drug on the market. The selected formulation proved to be consistent with pharmacopoeial requirements. It was also in vitro similar (f2) to the original drug and the theoretical linear release profile, as well as robust and reproducible regarding in vitro release in different fasted gastro-intestinal conditions. This is proof of concept that 24-h, specific, and almost linear release profile of drugs with high solubility can be achieved by employing technology of coated matrix mini-tablets. Copyright © 2015 Elsevier B.V. All rights reserved.


Related Compounds

Related Articles:

Salicylic acid signaling controls the maturation and localization of the arabidopsis defense protein ACCELERATED CELL DEATH6.

2014-08-01

[Mol. Plant 7(8) , 1365-83, (2014)]

Gene transfer of high-mobility group box 1 box-A domain in a rat acute liver failure model.

2015-04-01

[J. Surg. Res. 194(2) , 571-80, (2015)]

DNase II-dependent DNA digestion is required for DNA sensing by TLR9.

2015-01-01

[Nat. Commun. 6 , 5853, (2015)]

The dual FAAH/MAGL inhibitor JZL195 has enhanced effects on endocannabinoid transmission and motor behavior in rats as compared to those of the MAGL inhibitor JZL184.

2014-09-01

[Pharmacol. Biochem. Behav. 124 , 153-9, (2014)]

Crystal structures and kinetics of Type III 3-phosphoglycerate dehydrogenase reveal catalysis by lysine.

2014-12-01

[FEBS J. 281(24) , 5498-512, (2014)]

More Articles...